Dolby Laboratories (NYSE:DLB) Downgraded to Hold Rating by Wall Street Zen

Dolby Laboratories (NYSE:DLB) was downgraded by research analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a report released on Sunday.

Several other research analysts also recently weighed in on the stock. Weiss Ratings restated a “hold (c-)” rating on shares of Dolby Laboratories in a research report on Monday, December 22nd. Baird R W raised Dolby Laboratories to a “hold” rating in a report on Friday, September 5th. Robert W. Baird started coverage on Dolby Laboratories in a research report on Friday, September 5th. They issued a “neutral” rating and a $74.00 target price on the stock. Barrington Research lowered their price target on Dolby Laboratories from $100.00 to $95.00 and set an “outperform” rating on the stock in a research note on Wednesday, November 19th. Finally, Rosenblatt Securities reduced their price objective on Dolby Laboratories from $95.00 to $85.00 and set a “buy” rating for the company in a research note on Wednesday, November 19th. Three investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $92.00.

Dolby Laboratories Stock Performance

Shares of NYSE:DLB opened at $65.69 on Friday. Dolby Laboratories has a one year low of $64.02 and a one year high of $89.66. The firm’s 50 day simple moving average is $66.51 and its 200-day simple moving average is $70.81. The firm has a market cap of $6.27 billion, a PE ratio of 24.98 and a beta of 0.89.

Dolby Laboratories (NYSE:DLB) last announced its earnings results on Tuesday, November 18th. The electronics maker reported $0.99 earnings per share for the quarter, topping the consensus estimate of $0.70 by $0.29. Dolby Laboratories had a return on equity of 11.99% and a net margin of 18.90%.The business had revenue of $307.02 million during the quarter, compared to the consensus estimate of $305.76 million. During the same period in the prior year, the company posted $0.61 EPS. The business’s quarterly revenue was up .7% on a year-over-year basis. Dolby Laboratories has set its FY 2026 guidance at 4.190-4.340 EPS and its Q1 2026 guidance at 0.790-0.940 EPS. Equities research analysts predict that Dolby Laboratories will post 2.94 EPS for the current fiscal year.

Insider Activity at Dolby Laboratories

In related news, SVP John D. Couling sold 7,273 shares of Dolby Laboratories stock in a transaction on Thursday, December 11th. The stock was sold at an average price of $68.75, for a total value of $500,018.75. Following the transaction, the senior vice president owned 108,065 shares in the company, valued at approximately $7,429,468.75. This trade represents a 6.31% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Kevin J. Yeaman sold 6,751 shares of the business’s stock in a transaction dated Wednesday, December 17th. The shares were sold at an average price of $67.24, for a total value of $453,937.24. Following the sale, the chief executive officer directly owned 98,377 shares of the company’s stock, valued at approximately $6,614,869.48. This trade represents a 6.42% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 162,120 shares of company stock valued at $10,906,559 in the last ninety days. 37.93% of the stock is owned by company insiders.

Institutional Trading of Dolby Laboratories

Large investors have recently bought and sold shares of the company. Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its stake in shares of Dolby Laboratories by 7.8% during the second quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 15,777 shares of the electronics maker’s stock valued at $1,172,000 after acquiring an additional 1,146 shares during the period. Campbell & CO Investment Adviser LLC lifted its position in Dolby Laboratories by 193.2% in the second quarter. Campbell & CO Investment Adviser LLC now owns 17,275 shares of the electronics maker’s stock worth $1,283,000 after purchasing an additional 11,384 shares during the period. Boston Trust Walden Corp boosted its stake in Dolby Laboratories by 2.1% during the 2nd quarter. Boston Trust Walden Corp now owns 1,098,218 shares of the electronics maker’s stock valued at $81,554,000 after purchasing an additional 22,404 shares in the last quarter. Sequoia Financial Advisors LLC acquired a new position in shares of Dolby Laboratories during the 2nd quarter valued at $550,000. Finally, Clifford Capital Partners LLC raised its stake in shares of Dolby Laboratories by 3.1% in the 2nd quarter. Clifford Capital Partners LLC now owns 264,059 shares of the electronics maker’s stock worth $19,609,000 after buying an additional 7,871 shares in the last quarter. Institutional investors and hedge funds own 58.56% of the company’s stock.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.